Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (541-550 of 633) with videos related to

Pageof 64
Sort By:
Journal of Gastroenterology and Hepatology|March 25, 2016
Flares during long-term entecavir therapy in chronic hepatitis BHeng Chi, Pauline Arends, Jurriën G P Reijnders, et al.
Journal of Hepatology|August 10, 2018
Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in GermanyKerstin Herzer, Guido Gerken, Daniela Kroy, et al.
Journal of Hepatology|August 23, 2016
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised studyScott Fung, Peter Kwan, Milotka Fabri, et al.
Gastroenterology|November 18, 2017
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting AntiviralsJulia Dietz, Simone Susser, Johannes Vermehren, et al.
Hepatology International|March 7, 2026
Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-studyKatrin Splith, Nadja Berndt, Philipp K Haber, et al.
JHEP Reports : Innovation in Hepatology|July 15, 2024
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, Christiana Graf, Christoph P Berg, et al.
United European Gastroenterology Journal|July 15, 2024
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trialAlexey Surov, Andreas Wienke, Jan Borggrefe, et al.
Plos One|June 5, 2013
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentChristian M Lange, Daiki Miki, Hidenori Ochi, et al.
Hepatology (Baltimore, Md.)|August 8, 2015
A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearanceHui Wang, Souhayla El Maadidi, Janett Fischer, et al.
Digestive Diseases (Basel, Switzerland)|April 29, 2026
Bone mineral density does not predict overall survival in patients with advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trialMaximilian Thormann, Andreas Wienke, Ricarda Seidensticker, et al.
Pageof 64

Showing results (541-550 of 633) with videos related to

Sort By:
Pageof 64
Journal of Gastroenterology and Hepatology|March 25, 2016
Flares during long-term entecavir therapy in chronic hepatitis BHeng Chi, Pauline Arends, Jurriën G P Reijnders, et al.
Journal of Hepatology|August 10, 2018
Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in GermanyKerstin Herzer, Guido Gerken, Daniela Kroy, et al.
Journal of Hepatology|August 23, 2016
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised studyScott Fung, Peter Kwan, Milotka Fabri, et al.
Gastroenterology|November 18, 2017
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting AntiviralsJulia Dietz, Simone Susser, Johannes Vermehren, et al.
Hepatology International|March 7, 2026
Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-studyKatrin Splith, Nadja Berndt, Philipp K Haber, et al.
JHEP Reports : Innovation in Hepatology|July 15, 2024
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, Christiana Graf, Christoph P Berg, et al.
United European Gastroenterology Journal|July 15, 2024
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trialAlexey Surov, Andreas Wienke, Jan Borggrefe, et al.
Plos One|June 5, 2013
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentChristian M Lange, Daiki Miki, Hidenori Ochi, et al.
Hepatology (Baltimore, Md.)|August 8, 2015
A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearanceHui Wang, Souhayla El Maadidi, Janett Fischer, et al.
Digestive Diseases (Basel, Switzerland)|April 29, 2026
Bone mineral density does not predict overall survival in patients with advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trialMaximilian Thormann, Andreas Wienke, Ricarda Seidensticker, et al.
Pageof 64